In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.
The in vitro interactions of two new antitubercular drugs, SQ109 and TMC207, with each other and with rifampin (RIF) were evaluated. The combination of SQ109 with TMC207 (i) improved an already excellent TMC207 MIC for M. tuberculosis H37Rv by 4- to 8-fold, (ii) improved the rate of killing of bacteria over the rate of killing by each single drug, and (iii) enhanced the drug postantibiotic effect by 4 h. In no instance did we observe antagonistic activities with the combination of SQ109 and TMC207. Rifampin activates cytochrome P450 genes to reduce the area under the curve (AUC) for TMC207 in humans. The presence of RIF in three-drug combinations did not affect the synergistic activities of SQ109 and TMC207, and SQ109 also dramatically decreased the MIC of RIF. SQ109 was active by itself, and both its activity was improved by and it improved the in vitro activities of both RIF and TMC207.
Reddy
Venkata M
VM
Sequella, Inc., 9610 Medical Center Drive, Suite 200, Rockville, MD 20850, USA. venkatareddy@sequella.com
Einck
Leo
L
Andries
K
K
Nacy
Carol A
CA
D000218:Adamantane / Q000031:analogs & derivatives* / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology*; D064687:Diarylquinolines; D004347:Drug Interactions; D005029:Ethylenediamines / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011804:Quinolines / Q000494:pharmacology*; D012293:Rifampin / Q000494:pharmacology*
D000995:Antitubercular Agents; D064687:Diarylquinolines; D005029:Ethylenediamines; C506841:N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine; D011804:Quinolines; C493870:bedaquiline; D000218:Adamantane; D012293:Rifampin
Antimicrob Agents Chemother. 2007 Mar;51(3):1011-5
17178794
Antimicrob Agents Chemother. 1992 Mar;36(3):548-51
1622164
J Infect Dis. 2007 Aug 15;196 Suppl 1:S28-34
17624823
J Clin Microbiol. 1986 Dec;24(6):976-81
3097069
J Antimicrob Chemother. 2003 Jul;52(1):1
12805255
Antimicrob Agents Chemother. 1995 Feb;39(2):440-4
7726512
Science. 2005 Jan 14;307(5707):223-7
15591164
Antimicrob Agents Chemother. 2008 Feb;52(2):719-21
18070956
Antimicrob Agents Chemother. 2004 Jan;48(1):340-3
14693563
J Antimicrob Chemother. 2006 Aug;58(2):332-7
16751637
J Antimicrob Chemother. 2005 Nov;56(5):968-74
16172107
Chest. 1997 May;111(5):1168-73
9149565
J Comb Chem. 2003 Mar-Apr;5(2):172-87
12625709
Antimicrob Agents Chemother. 2008 Oct;52(10):3568-72
18644960
Antimicrob Agents Chemother. 2007 Apr;51(4):1563-5
17242141
Infect Immun. 1999 Sep;67(9):4586-93
10456904